These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10815759)

  • 1. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
    Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
    J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cell cycle-dependent cytotoxicity and apoptosis by new heterodinucleoside phosphate dimers of 5-fluorodeoxyuridine in PC-3 human prostate cancer cells.
    Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Derighetti M; Schwendener RA
    Biochem Pharmacol; 2000 Dec; 60(12):1887-96. PubMed ID: 11108805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145.
    Cattaneo-Pangrazzi RM; Schott H; Schwendener RA
    Prostate; 2000 Sep; 45(1):8-18. PubMed ID: 10960838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
    Strasser S; Maier S; Leisser C; Saiko P; Madlener S; Bader Y; Bernhaus A; Gueorguieva M; Richter S; Mader RM; Wesierska-Gadek J; Schott H; Szekeres T; Fritzer-Szekeres M; Krupitza G
    Differentiation; 2006 Dec; 74(9-10):488-98. PubMed ID: 17177846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
    Grem JL; Danenberg KD; Kao V; Danenberg PV; Nguyen D
    Anticancer Drugs; 2002 Mar; 13(3):259-70. PubMed ID: 11984070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
    Ren Q; Kao V; Grem JL
    Clin Cancer Res; 1998 Nov; 4(11):2811-8. PubMed ID: 9829747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
    Maier S; Strasser S; Saiko P; Leisser C; Sasgary S; Grusch M; Madlener S; Bader Y; Hartmann J; Schott H; Mader RM; Szekeres T; Fritzer-Szekeres M; Krupitza G
    Apoptosis; 2006 Mar; 11(3):427-40. PubMed ID: 16538382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
    Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J
    Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
    McGinn CJ; Miller EM; Lindstrom MJ; Kunugi KA; Johnston PG; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):851-9. PubMed ID: 7960987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.
    Flanagan SA; Cooper KS; Mannava S; Nikiforov MA; Shewach DS
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e613-20. PubMed ID: 22867891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.
    Huehls AM; Wagner JM; Huntoon CJ; Geng L; Erlichman C; Patel AG; Kaufmann SH; Karnitz LM
    Cancer Res; 2011 Jul; 71(14):4944-54. PubMed ID: 21613406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.
    Bijnsdorp IV; Schwendener RA; Schott H; Fichtner I; Smid K; Laan AC; Schott S; Losekoot N; Honeywell RJ; Peters GJ
    Invest New Drugs; 2011 Apr; 29(2):248-57. PubMed ID: 19957099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.
    Murakami Y; Kazuno H; Emura T; Tsujimoto H; Suzuki N; Fukushima M
    Int J Oncol; 2000 Aug; 17(2):277-83. PubMed ID: 10891536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression.
    Lawrence TS; Davis MA; Tang HY; Maybaum J
    Int J Radiat Biol; 1996 Sep; 70(3):273-80. PubMed ID: 8800198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of thymidylate synthase activity by antisense oligodeoxynucleotide and possible role in thymineless treatment.
    Lin SB; Ts'o PO; Sun SK; Choo KB; Yang FY; Lim YP; Tsai HL; Au LC
    Mol Pharmacol; 2001 Sep; 60(3):474-9. PubMed ID: 11502877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
    Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
    Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different modes of cell death induced by 5-fluoro-2'-deoxyuridine in two clones of the mouse mammary tumor FM3A cell line.
    Kakutani T; Ebara Y; Kanja K; Hidaka M; Matsumoto Y; Nagano A; Wataya Y
    Biochem Biophys Res Commun; 1998 Jun; 247(3):773-9. PubMed ID: 9647769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.